OONI Health Partners Talk to us
Independent Musculoskeletal Review · UK Insurers and Employers

The independent consultant layer for the musculoskeletal pathway.

ONI Health Partners is a panel of named consultant orthopaedic surgeons who review musculoskeletal cases at the two points where cost and outcomes are decided: before a referral becomes a claim, and before a claim becomes an operation. The reviewing surgeon never operates on the case, and is paid the same whichever way the decision goes. That independence is the product.

For insurers For direct employers
Light filtering through wooden louvres — the upstream triage metaphor
The economic case
£200–£400
Per covered employee, per year. UK musculoskeletal claim cost on a typical corporate medical policy.
A meaningful share of it avoidable. An early review by a named consultant orthopaedic surgeon identifies the cases that never needed a surgical pathway, before the cost and the risk are incurred.
Skou et al. 2022, Journal of Orthopaedic & Sports Physical Therapy. 100 RCTs, 12,645 patients.
Where the money is going

Musculoskeletal is the largest preventable cost line in UK workforce health insurance.

UK private medical insurers paid out roughly £4 to £5 billion in claims in 2024, with musculoskeletal sitting in the top three cost categories by spend alongside cancer and mental health. Bupa alone reported insurance service expense of £3.2 billion in 2024, with claims inflation cited as a primary driver of rising loss ratios across the corporate book.

The musculoskeletal share of that spend is structurally avoidable. Most cases that progress to consultant referral, imaging, or surgery do not require surgical management. They require correct early review by an experienced clinician, and the existing pathway does not reliably provide it.

For insurers, that means tens to hundreds of millions of pounds in annual claim cost that does not need to be there. For corporate policy-holders, it means premium inflation year after year and absence costs the people-function cannot defend at board level.

The Employment Rights Act 2025 has now made statutory sick pay payable from the first day of absence, putting workforce musculoskeletal cost on the people-function profit and loss for the first time. The two cost lines, claims and absence, are increasingly being read together.

£200–£400
Estimated annual musculoskeletal claim cost per covered employee in a typical UK corporate private medical insurance policy
7.1m
Working days lost to musculoskeletal conditions in Great Britain per year (Health and Safety Executive, 2024–25)
The evidence base

The clinical case for upstream triage is established.

The clinical evidence supporting consultant-led conservative triage is now strong and replicated across multiple high-quality reviews.

"For most musculoskeletal conditions with sufficient data, there were no clinically relevant differences between interventions with and without surgery." Skou et al., systematic review and meta-analysis of 100 randomised controlled trials across 28 musculoskeletal conditions in 12,645 patients. Journal of Orthopaedic & Sports Physical Therapy, 2022.

The same conclusion is reinforced by the Keele University STarT Back trial (Hill et al., The Lancet, 2011), which demonstrated that stratified primary-care management for low back pain reduced time-off-work by 50% and delivered approximately £675 per patient in societal savings without increasing healthcare costs.

The implication for insurers is direct: a meaningful share of the musculoskeletal claims paid each year did not need to fire. The clinical service required to triage them out exists. It has not previously been packaged as an insurer-grade product. That is what ONI Health Partners builds.

For UK insurers

An independent surgeon-review layer at the two points in your pathway where the money is decided.

Most UK insurers already run physiotherapy-first triage and digital front doors, and they work for the cases that enter them. The expensive problem is the cases that bypass them: referrals arriving with a named consultant already attached, and procedures passing to authorisation without independent specialist scrutiny. That is where OHP sits.

At the front of the pathway, a named consultant orthopaedic surgeon reviews consultant-bound cases within 48 hours and answers one question: does this case need a surgeon at all? At the decision point, OHP reviews specified procedures against published evidence-based criteria before they are authorised. In both roles the reviewing surgeon is structurally independent. They never operate on the case they review, they hold their own clinical record and indemnity, and no OHP fee varies with the decision. Cases that need surgical or specialist care continue into your established claim pathway with a clear clinical record and a faster start.

I

Independent by design

The reviewing surgeon never operates on the case, never refers it into their own practice, and holds their own clinical record and indemnity. Independence protects the member, the treating consultant, and the insurer's clinical governance in equal measure.

48h

Review within 48 hours

A named consultant orthopaedic surgeon reviews the case within 48 hours. Speed matters as much as scrutiny: members are not left waiting, and treating-clinician relationships are protected rather than obstructed.

=

Paid for being right, not for saying no

OHP's fee is identical whether a case is progressed or redirected. Any performance element is tied to independently verified member outcomes at twelve months, and a fast-tracked case that did need surgery counts as a success. The structure removes the incentive to deny care, and it is auditable.

How an insurer partnership works

An audit first. A pilot second. A scaled partnership third.

1

Claims pathway audit (4–6 weeks)

Retrospective analysis of your last 12 months of musculoskeletal claims. Output is a board-level memo: the avoidable-claim share, the cost concentration by sub-specialty, and a modelled annual saving if upstream triage had been in place. Delivered under confidentiality agreement.

2

Pilot deployment (6 months)

OHP reviews cases for a defined population of covered lives. Review outcomes, member experience and claim trajectories are tracked monthly against a matched historical baseline agreed before the pilot starts. Pilots are priced lean deliberately: the objective is a clean, auditable result, not early fees.

3

Scaled partnership (12+ months)

Once the pilot verifies, the service scales across the relevant book. Commercial terms are value-based and shaped to the portfolio, with any performance element tied to verified twelve-month outcomes rather than case volume. Co-branded or wraparound delivery, with quarterly reporting to strategy, product and underwriting teams.

For employers and health trusts

The same review layer, bought directly.

Where an employer or a corporate healthcare trust wants OHP without waiting for their insurer to bring it, we work on two shapes. A flat fee per case reviewed, for organisations with a steady flow of musculoskeletal absence, referrals or claims. Or a whole-workforce arrangement priced against working days lost rather than benefits spend. In both, the fee never depends on the outcome of any individual review.

Commercial terms are shaped to headcount and case volume. The most useful first conversation starts with two numbers: how many staff, and how many musculoskeletal cases or claims a year.

Mr Tofunmi Oni, Consultant Orthopaedic Surgeon and Founder of ONI Health Partners
Founder & principal

Mr Tofunmi Oni

Consultant orthopaedic surgeon in the National Health Service, specialising in complex hip and knee surgery. Private practice across Kent, Sussex, and London.

ONI Health Partners is a service brand operated as the corporate division of ONI Orthopaedics Limited. The founding panel covers hip and knee, spine, shoulder and elbow, foot and ankle, and hand and wrist. Each covered member is matched to the right named consultant for their condition. Mr Oni serves as the named principal and relationship lead for every insurer and direct-employer engagement.

  • NHS: Consultant orthopaedic surgeon, substantive post
  • Speciality: Complex hip and knee reconstruction
  • Private practice: Kent, Sussex, London
  • Founding panel: Sub-specialty consultants across the main musculoskeletal regions
  • Advisory: Brightland (equity-holding advisor)
Talk to us

Two ways in.

Insurers and partnership teams

For private medical insurers, group income protection providers, healthcare trust administrators, brokers and intermediaries exploring an independent review layer.

Insurer enquiry

HR Directors and Heads of People

For UK employers considering per-case review or a whole-workforce arrangement before their insurer offers OHP.

Employer enquiry

tofunmi@onihealthpartners.co.uk